Teamwork Financial Advisors LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 689.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,509 shares of the healthcare conglomerate's stock after acquiring an additional 3,938 shares during the quarter. Teamwork Financial Advisors LLC's holdings in UnitedHealth Group were worth $1,407,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. Brighton Jones LLC grew its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Polar Asset Management Partners Inc. purchased a new position in UnitedHealth Group during the 4th quarter worth $1,973,000. Redwood Investment Management LLC grew its position in UnitedHealth Group by 73.1% during the 4th quarter. Redwood Investment Management LLC now owns 1,376 shares of the healthcare conglomerate's stock worth $696,000 after purchasing an additional 581 shares during the last quarter. Finally, Silvercrest Asset Management Group LLC increased its stake in shares of UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock worth $19,625,000 after acquiring an additional 12,550 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Price Performance
Shares of UNH stock traded down $1.00 during trading hours on Friday, hitting $352.61. The company's stock had a trading volume of 13,985,550 shares, compared to its average volume of 16,174,808. The business has a fifty day moving average of $291.98 and a 200-day moving average of $368.31. The stock has a market cap of $319.35 billion, a price-to-earnings ratio of 15.28, a P/E/G ratio of 2.30 and a beta of 0.44. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio is currently 38.30%.
Analyst Ratings Changes
UNH has been the topic of a number of recent analyst reports. Royal Bank Of Canada dropped their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 30th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research note on Wednesday, May 21st. KeyCorp dropped their price target on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Finally, Piper Sandler lowered their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus target price of $358.95.
Read Our Latest Analysis on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.